Terms: = Liver cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884
217 results:
1. Investigation of folate-modified EGCG-loaded thermosensitive nanospheres inducing immunogenic cell death and damage-associated molecular patterns in hepatocellular carcinoma.
He L; Peng L; Wang L; Jiang X; Sun X; Li H; Lin T; Wu Z; Lin S
Biochem Biophys Res Commun; 2024 Jun; 714():149976. PubMed ID: 38677007
[TBL] [Abstract] [Full Text] [Related]
2. Tracing genetic diversity captures the molecular basis of misfolding disease.
Zhao P; Wang C; Sun S; Wang X; Balch WE
Nat Commun; 2024 Apr; 15(1):3333. PubMed ID: 38637533
[TBL] [Abstract] [Full Text] [Related]
3. Integrated network toxicology, molecular docking, and in vivo experiments to elucidate molecular mechanism of aflatoxin B1 hepatotoxicity.
Ge B; Yan K; Sang R; Wang W; Liu X; Yu M; Liu X; Qiu Q; Zhang X
Ecotoxicol Environ Saf; 2024 Apr; 275():116278. PubMed ID: 38564860
[TBL] [Abstract] [Full Text] [Related]
4. USP21 deubiquitinates and stabilizes hsp90 and ENO1 to promote aerobic glycolysis and proliferation in cholangiocarcinoma.
Xu X; Chen Y; Shao S; Wang J; Shan J; Wang Y; Wang Y; Chang J; Zhou T; Chen R; Liu S; Li C; Li C; Li X
Int J Biol Sci; 2024; 20(4):1492-1508. PubMed ID: 38385089
[TBL] [Abstract] [Full Text] [Related]
5. Tumor cell-derived LC3B
Chen YQ; Man ZS; Zheng L; Zhang Y; Zhao CW; Ma YT; Zhou J; Wang P; Yu Y; Gu F; Niu GP
Clin Immunol; 2024 Apr; 261():109925. PubMed ID: 38310993
[TBL] [Abstract] [Full Text] [Related]
6. hsp90a promotes the resistance to oxaliplatin in HCC through regulating IDH1-induced cell competition.
Wang S; Cheng H; Huang Y; Li M; Gao D; Chen H; Su R; Guo K
Biochim Biophys Acta Mol Cell Res; 2024 Mar; 1871(3):119680. PubMed ID: 38280407
[TBL] [Abstract] [Full Text] [Related]
7. Exploration of the Pharmacological Mechanism of Vitexicarpin against Triple-Negative Breast cancer in Network Pharmacology.
Wu T; Xiang M; Li Y; Gao Y; Teng D; Sun M; Guo W; Zhou Y
Front Biosci (Landmark Ed); 2023 Dec; 28(12):341. PubMed ID: 38179762
[TBL] [Abstract] [Full Text] [Related]
8. Synergistic induction of apoptosis in liver cancer cells: exploring the combined potential of doxorubicin and XL-888.
Kaplan Ö
Med Oncol; 2023 Oct; 40(11):318. PubMed ID: 37794195
[TBL] [Abstract] [Full Text] [Related]
9. hsp90, as a functional target antigen of a mAb 11C9, promotes stemness and tumor progression in hepatocellular carcinoma.
Liu HQ; Sun LX; Yu L; Liu J; Sun LC; Yang ZH; Shu X; Ran YL
Stem Cell Res Ther; 2023 Sep; 14(1):273. PubMed ID: 37759328
[TBL] [Abstract] [Full Text] [Related]
10. hsp90 C-terminal domain inhibition promotes VDAC1 oligomerization via decreasing K274 mono-ubiquitination in Hepatocellular Carcinoma.
Zhang J; Liu L; Li Y; Huang Y; Xiao S; Deng Z; Zheng Z; Li J; Liang M; Xie G; Chen X; Deng Y; Tan W; Su H; Wu G; Cai C; Chen X; Zou F
Neoplasia; 2023 Oct; 44():100935. PubMed ID: 37717471
[TBL] [Abstract] [Full Text] [Related]
11. USP14 governs CYP2E1 to promote nonalcoholic fatty liver disease through deubiquitination and stabilization of hsp90aa1.
Wei D; Tian X; Zhu L; Wang H; Sun C
Cell Death Dis; 2023 Aug; 14(8):566. PubMed ID: 37633951
[TBL] [Abstract] [Full Text] [Related]
12. [STIP1 correlates with tumor immune infiltration and prognosis as a potential immunotherapy target: a pan-cancer bioinformatics analysis].
Guan S; Shen Z; Lin M; Deng H; Fang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jul; 43(7):1179-1193. PubMed ID: 37488801
[TBL] [Abstract] [Full Text] [Related]
13. An HBV susceptibility variant of KNG1 modulates the therapeutic effects of interferons α and λ1 in HBV infection by promoting MAVS lysosomal degradation.
Zhang B; Han H; Zhao X; Li AN; Wang Y; Yuan W; Yang Z; Li MD
EBioMedicine; 2023 Aug; 94():104694. PubMed ID: 37442062
[TBL] [Abstract] [Full Text] [Related]
14. Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression.
Wang S; Zhou L; Ji N; Sun C; Sun L; Sun J; Du Y; Zhang N; Li Y; Liu W; Lu W
Drug Resist Updat; 2023 Jul; 69():100976. PubMed ID: 37210811
[TBL] [Abstract] [Full Text] [Related]
15. Histone chaperone SSRP1 is required for apoptosis inhibition and mitochondrial function in HCC via transcriptional promotion of TRAP1.
Chen X; Li M; Wang D; Wang Q; Wei X; Liu X; Yang J; Kalvakolanu DV; Guo B; Zhang L
Biochem Cell Biol; 2023 Aug; 101(4):361-376. PubMed ID: 37084412
[TBL] [Abstract] [Full Text] [Related]
16. Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating hsp90 mediated GPX4 ubiquitination and degradation.
Zhou C; Yu T; Zhu R; Lu J; Ouyang X; Zhang Z; Chen Q; Li J; Cui J; Jiang F; Jin KY; Sarapultsev A; Li F; Zhang G; Luo S; Hu D
Int J Biol Sci; 2023; 19(5):1471-1489. PubMed ID: 37056925
[TBL] [Abstract] [Full Text] [Related]
17. Impact of FKBP52 on cell proliferation and hormone-dependent cancers.
Hanaki S; Shimada M
Cancer Sci; 2023 Jul; 114(7):2729-2738. PubMed ID: 37026526
[TBL] [Abstract] [Full Text] [Related]
18. Integrated metabolomics and phosphoproteomics reveal the protective role of exosomes from human umbilical cord mesenchymal stem cells in naturally aging mouse livers.
Ling M; Tang C; Yang X; Yu N; Song Y; Ding W; Sun Y; Yan R; Wang S; Li X; Gao H; Zhang Z; Xing Y
Exp Cell Res; 2023 Jun; 427(1):113566. PubMed ID: 37004949
[TBL] [Abstract] [Full Text] [Related]
19. Construction of endothelial cell-related and autophagy-related prognostic models for hepatocellular carcinoma based on single-cell data.
Mou L; Li K; Xu C; Xu I; Yang Y; Pu Z
J Gastroenterol Hepatol; 2023 May; 38(5):809-820. PubMed ID: 36894323
[TBL] [Abstract] [Full Text] [Related]
20. Network pharmacology and in vivo studies reveal the pharmacological effects and molecular mechanisms of Celastrol against acute hepatic injury induced by LPS.
Yang T; Zhao S; Sun N; Zhao Y; Wang H; Zhang Y; Hou X; Tang Y; Gao X; Fan H
Int Immunopharmacol; 2023 Apr; 117():109898. PubMed ID: 36827925
[TBL] [Abstract] [Full Text] [Related]
[Next]
